Technology News and Research

RSS

Polycom's scalable solutions for the healthcare industry

Polycom, Inc., the global leader in telepresence, video and voice communication solutions, is making it easier and more cost-effective for hospitals and other healthcare organizations to deploy and scale telehealth and telemedicine networks. Through an enhanced, highly scalable solution, Polycom allows healthcare organizations to easily and securely extend visual communication capabilities outside of their private networks to a broader group of partner hospitals, community clinics and physicians.

24 Sep 2009

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

CEL-SCI Corporation (NYSE AMEX: CVM), a developer of vaccines and therapeutics for the treatment of infectious diseases and a late-stage oncology company, announced today that it has hired a full-service Clinical Research Organization (CRO) with an office in the Washington, D.C./Baltimore area to support its conduct of the upcoming clinical trial of its investigational LEAPS-H1N1 treatment.

24 Sep 2009

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.

24 Sep 2009

Study reveals that AIR Inhaled Insulin is inferior to SC insulin

The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia

24 Sep 2009

ImThera Medical completes THN system development

ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).

24 Sep 2009

AmeriChoice of Pennsylvania, Chester County Hospital sign agreement for access to hospital's facilities

AmeriChoice of Pennsylvania and Chester County Hospital have announced an agreement that will provide AmeriChoice Medicaid members access to the hospital’s inpatient and outpatient facilities.

24 Sep 2009

RFID asset management agreements offered by Premier Purchasing Partners

Premier Purchasing Partners, LP, today announced new agreements have taken effect in a new radio frequency identification (RFID) asset management and tracking solution category. The agreements have been awarded to AeroScout Inc. of Redwood City, Calif.; Dynamic Computer Corporation of Farmington Hills, Mich., a minority owned business enterprise; International Business Solutions Alliance, LLC of Dayton, Ohio; and Skytron of Grand Rapids, Mich.

24 Sep 2009

Guarding Hearts Alliance to protect quality care for patients suffering from heart disease

Organizations representing the vast majority of cardiologists around the country have joined forces today to preserve and protect the highest quality cardiac care available in America. Guarding Hearts Alliance is advocating to protect patient access to cardiac care in whatever Medicare changes or health care reform legislation is enacted.

24 Sep 2009

Handheld diabetic test from MSGI's Nanobeak

MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the Company is launching its first product derived from NASA technology, a handheld test for Diabetes, which uses breath instead of blood.

24 Sep 2009

FDA endorses Covidien's REMS program for EXALGO tablets

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it presented information to members of a U.S. Food and Drug Administration (FDA) Advisory Committee on the New Drug Application and proposed Risk Evaluation and Mitigation Strategy (REMS) program for EXALGOTM (hydromorphone HCl extended release) tablets, an opioid formulation.

24 Sep 2009

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced today by Cook Medical at TCT 2009. The release of the NavAlign™ delivery system marks the 20th anniversary of Cook’s first IVC filter and further advances the treatment of pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lungs that affects thousands of Americans annually.

24 Sep 2009

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Lux Biosciences, Inc. a privately held biotechnology company focused on the treatment of ophthalmic diseases, today announced results from a Phase 1 human safety and an open-label pilot efficacy study of the company’s potential best-in-class therapy for dry eye, LX214 (topical mixed nanomicellar formulation of voclosporin).

24 Sep 2009

DATATRAK International signs two clinical studies

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of two worldwide studies exemplifying the versatility of the DATATRAK eClinical platform.

24 Sep 2009

IOM study to examine premarket notification program for medical devices

The U.S. Food and Drug Administration today announced that it has commissioned the Institute of Medicine (IOM) to study the premarket notification program used to review and clear certain medical devices marketed in the United States.

24 Sep 2009

E-18 Corp. enters dental syringe market, completes US patent filing for the Protectus Safety Dental Syringe

E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company’s market opportunities to include the multi-billion dollar dental syringe market.

24 Sep 2009

Electrically stimulating nerve cells can restore some vision

Results: MIT engineers have designed a retinal implant for people who have lost their vision from retinitis pigmentosa or age-related macular degeneration, two of the leading causes of blindness. The retinal prosthesis would help restore some vision by electrically stimulating the nerve cells that normally carry visual input from the retina to the brain.

24 Sep 2009

VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new ReninSense680(TM) FAST imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo.

24 Sep 2009

Technology News and Research

Polycom's scalable solutions for the healthcare industry

CEL-SCI Corporation engages a CRO for clinical trial of its investigational LEAPS-H1N1 treatment

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

Study reveals that AIR Inhaled Insulin is inferior to SC insulin

ImThera Medical completes THN system development

AmeriChoice of Pennsylvania, Chester County Hospital sign agreement for access to hospital's facilities

RFID asset management agreements offered by Premier Purchasing Partners

Guarding Hearts Alliance to protect quality care for patients suffering from heart disease

Handheld diabetic test from MSGI's Nanobeak

FDA endorses Covidien's REMS program for EXALGO tablets

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

DATATRAK International signs two clinical studies

IOM study to examine premarket notification program for medical devices

E-18 Corp. enters dental syringe market, completes US patent filing for the Protectus Safety Dental Syringe

Electrically stimulating nerve cells can restore some vision

VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker

KIKA releases the Veracity 3.7 advanced EDC solution for clinical trial management

Robust growth for Avizent despite weak economy

Cambridge Heart's modified Alternans technology to identify myocardial ischemia

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News